4-chloromercuribenzenesulfonate has been researched along with Liver Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernas, T; Dobrucki, J | 1 |
Knowles, AF; Murray, SL | 1 |
Chiles, TC; Kilberg, MS | 1 |
3 other study(ies) available for 4-chloromercuribenzenesulfonate and Liver Neoplasms
Article | Year |
---|---|
Extracellular reduction of Cat1 free radical by transformed human hepatocytes.
Topics: 4-Chloromercuribenzenesulfonate; Ascorbic Acid; Calcium Channels; Carcinoma, Hepatocellular; Catalase; Cell Line, Transformed; Cell Membrane; Doxorubicin; Extracellular Matrix; Free Radicals; Humans; Liver Neoplasms; NAD; Oxidation-Reduction; Tetrazoles; Tetrazolium Salts; TRPV Cation Channels | 1998 |
Butyrate induces an ectoMg2(+)-ATPase activity in Li-7A human hepatoma cells.
Topics: 4-Chloromercuribenzenesulfonate; Adenosine Triphosphatases; Biological Transport, Active; Bucladesine; Butyrates; Carcinoma, Hepatocellular; Cell Division; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Induction; Epidermal Growth Factor; Fatty Acids; Humans; Kinetics; Liver Neoplasms; Neoplasm Proteins; Time Factors; Tumor Cells, Cultured | 1990 |
System A transport activity in normal rat hepatocytes and transformed liver cells: substrate protection from inactivation by sulfhydryl-modifying reagents.
Topics: 4-Chloromercuribenzenesulfonate; Amino Acids; Aminoisobutyric Acids; Animals; Biological Transport; Bromosuccinimide; Carcinoma, Hepatocellular; Cell Line; Ethylmaleimide; Humans; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Rats; Rats, Inbred Strains; Sodium; Sulfhydryl Reagents | 1986 |